Evaluation of ginger as an adjunct therapy in Generalized Anxiety Disorder

Phase 2

• Conditions: Generalized Anxiety Disorder (GAD).; Generalized anxiety disorder; F41.1

• Registration Number: IRCT20201108049306N1
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Diagnosis of Generalized Anxiety Disorder by a physician based on the Hamilton Anxiety Rating Scale
The patient has filled in the consent form and consciously enters the study and cooperates
Age group 18 to 65 years old

Exclusion Criteria

The patient is pregnant or breastfeeding
The patient has a major co-morbid psychological disorder (including depressive disorder, bipolar disorder, psychosis, and drug use)
The patient has taken any antioxidant medication or supplement in the past month
Taking medicine that has interaction with ginger
The patient has co-morbid disease (other than neurological diseases)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score of anxiety based on the Hamilton Anxiety Rating Scale. Timepoint: Measurement of severity and extent of improvement of anxiety at the beginning of the study (before the intervention) and 14, 28, 56 and 84 days after the start of use. Method of measurement: Hamilton Anxiety Rating Scale.